Hosted on MSN

Sight Sciences (SGHT) Upgraded to Buy: Here's What You Should Know

Sight Sciences, Inc. (SGHT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Seeking Alpha

Sight Sciences Trying To Thread An Increasingly Narrow Needle

Sight Sciences continues to navigate significant reimbursement challenges, limiting revenue growth despite strong clinical evidence for its glaucoma and dry eye treatments. Recent headcount reductions ...
Fox 5 San Diego

Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023

MENLO PARK, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions ...
IFLScience

Sight-Restoring Eye Implant Gets People With Vision Loss Reading And Doing Crosswords

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
Hosted on MSN

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2024 Earnings Call Transcript

Operator: Hello, and welcome to the Sight Sciences Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be ...